Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Roman, Šefr"'
Autor:
Barbora Zwinsová, Vyacheslav A. Petrov, Martina Hrivňáková, Stanislav Smatana, Lenka Micenková, Natálie Kazdová, Vlad Popovici, Roman Hrstka, Roman Šefr, Beatrix Bencsiková, Lenka Zdražilová-Dubská, Veronika Brychtová, Rudolf Nenutil, Petra Vídeňská, Eva Budinská
Publikováno v:
Cancers, Vol 13, Iss 19, p 4799 (2021)
Long-term dysbiosis of the gut microbiome has a significant impact on colorectal cancer (CRC) progression and explains part of the observed heterogeneity of the disease. Even though the shifts in gut microbiome in the normal-adenoma-carcinoma sequenc
Externí odkaz:
https://doaj.org/article/29fb4d06ea9044ac81fb3352040678a3
Autor:
Oldřich Coufal, Tomáš Ostřížek, Petr Krsička, Eva Lžičařová, Rudolf Nenutil, Monika Procházková, Beatrix Bencsiková, Peter Grell, Roman Šefr
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-4 (2017)
Abstract Background Breast cancer can be diagnosed easily in most cases. However, occasionally, we are faced with some conditions that can mimic it. These may include inflammations, benign tumors, cysts, hematomas, or, more rarely, focal necrosis. Ca
Externí odkaz:
https://doaj.org/article/3d08397bd8b74d069b5e6b748570d612
Autor:
Roman Šefr, Lukáš Fiala, Vladimír Procházka, Martina Farkašová, Ondrej Slaby, Zdenek Kala, Tomáš Grolich, Michal Dosoudil, Tana Machackova, Ioana Berindan-Neagoe, Matej Skrovina, Karolina Trachtova, Marek Svoboda, Igor Kiss
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: Rectal cancer accounts for approximately one-third of all colorectal cancers. Currently, the standard treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (CRT) with capecitabine or 5-fluorouracil follo
Publikováno v:
Onkologie. 14:168-170
Autor:
Vlad Popovici, Eva Budinská, Barbora Zwinsová, Petra Vídeňská, Veronika Brychtová, Roman Šefr, Lenka Zdražilová-Dubská, Roman Hrstka, Lenka Micenková, Natálie Kazdová, Vyacheslav A. Petrov, Martina Hrivňáková, Rudolf Nenutil, Beatrix Bencsiková, Stanislav Smatana
BackgroundLong-term dysbiosis of the gut microbiome has a significant impact on the development, progression and the aggressiveness of colorectal cancer (CRC) and may explain part of the observed heterogeneity of the disease from phenotypic, prognost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17c88e8d58a58d0a9eee2914efd8869c
https://doi.org/10.21203/rs.3.rs-64049/v1
https://doi.org/10.21203/rs.3.rs-64049/v1
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 32(5)
Stage IV colorectal cancer is associated with high mortality, and the prognosis is significantly worse for patients have peritoneal metastases. Peritoneal carcinomatosis from colorectal cancer was considered incurable with an infaust prognosis. Media
Autor:
Eva Budinská, Rudolf Nenutil, Roman Šefr, Petra Vídeňská, Martina Hrivňáková, Veronika Brychtová, Beatrix Bencsiková, Barbora Zwinsová, Lenka Zdražilová-Dubská
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 32(4)
Background The clinical, histopathological, and molecular characteristics of colorectal cancer vary considerably. Factors associated with the heterogeneity of this disease and with understanding the effects of heterogeneity on disease progression and
Autor:
Eva Budinská, Lenka Fědorová, Roman Šefr, Iveta Selingerová, Kateřina Pilátová, Barbora Zwinsová, Marie Langrová, Veronika Brychtová, Lenka Zdražilová Dubská, Dalibor Valík, Beatrix Bencsiková
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 31(Suppl 2)
Background: Myeloid-derived suppressor cells (MDSCs) contribute to tumour escape from host immune surveillance and to tumour progression by producing tumour-promoting factors. We focused on clinical and analytical MDSCs-related issues as potential bi
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 31(3)
Mesenchymal malignancies are relatively rare tumors with distinct behaviors that are usually surgically removal. However, it is sometimes impossible to perform such surgery according to standardized procedures. In particular, surgical removal of intr
Publikováno v:
European Journal of Surgical Oncology. 46:e54